Continuing with our discussion of cholecystitis and cholelithiasis, in this lecture, we will discuss the risk factors for the cholelithiasis and acute cholecystitis, and the management of the cholecystitis.
Keep the following questions in mind while studying the notes or the video:
- What drugs can help against gallstone diseases?
- What drugs increase the risk of gallstone diseases?
- How to assess a patient's risk of cholelithiasis?
- What advice to offer about dietary and lifestyle habits to a person at risk of gallbladder diseases?
- Important risk factors for gallbladder diseases, including gallstones/cholelithiasis and eventual cholecystectomy.
We will discuss
- The risk factors for cholecystitis and cholelithiasis.
- The usual causes for the flare-ups
- The management approaches including:
- NSAIDs
- Cholecystectomy
- Ursodeoxycholic Acid
- Management consideration in the pregnant women.
In this lecture Dr. Mobeen will discuss:
1. Risk factors for cholelithiasis. (00:44)
2. Protective factors for gall bladder diseases. (3:02)
3. Acute cholelithiasis. (5:26)
4. Management of cholelithiasis. (9:06)
5. Indication for surgery. (11:58)
6. Use of ursodeoxycholic acid in treatment. (14:32)
Presented by Dr. Mobeen Syed
Faculty
In addition to the presenter, following authors may have helped with the content writing, review,
or approval:
CME, CE, CEU and Other Credit Types:
ACCME Accreditation Statement
The DrBeen Corp is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to
provide continuing medical education for physicians.
AMA Credit Designation Statement
The DrBeen Corp designates this enduring material for a maximum of 0.25 AMA PRA Category 1
Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the
activity.
Disclosure Information
In accordance with the disclosure policies of DrBeen Corp and the ACCME (Accreditation Council for
Continuing Medical Education), we are committed to upholding principles of balance, independence,
objectivity, and scientific rigor in all of our Continuing Medical Education (CME) and Continuing
Education (CE) activities. These policies include the careful management and mitigation of any relevant
financial relationships with organizations that are not eligible.
All members of the Activity Planning Committee and presenters have disclosed their relevant financial
relationships. The DrBeen Corp CE Committee has thoroughly reviewed these disclosures and determined
that these relationships are not deemed inappropriate in the context of their respective presentations.
Additionally, they are found to be consistent with the educational objectives and the integrity of the
activity.
| Faculty |
Disclosures |
| Dr. Mobeen Syed |
Author declares no conflict of interest. |
Write A New Comment
0 Comments